engage.agenabio.com Open in urlscan Pro
2606:2c40::c73c:67e1  Public Scan

Form analysis
0 forms found in the DOM

Text Content

By clicking “Accept,” you agree to allow Agena Bioscience and our partners to
use cookies to deliver our services and to show you relevant ads. To learn more,
see our Privacy Policy.

If you decline, your information won’t be tracked when you visit this website. A
single cookie will be used in your browser to remember your preference not to be
tracked.

Accept Decline
AGENA @ AMP 2023

Visit AMP.org


AMP-ING UP CLINICAL GENOMICS

Discover Innovative Solutions in Molecular Pathology
NEXT UP

WEDS 11/15 - 11:00 MT Rethinking Solid Tumor Profiling  More >

WELCOME
ONCOLOGY WORKSHOP
PGX WORKSHOP
SPEAKERS

Visit us at booth  #1011

Enabling Clinical Laboratories to Deliver Targeted Genomic Testing
In the dynamic world of oncology and PGx testing, labs face the complexities of
molecular profiling workflows and increasing demands to detect actionable
biomarkers. Agena Bioscience offers breakthrough solutions that streamline
operations, ensure sensitivity and accuracy, and set new standards for clinical
laboratories. Register for our oncology and PGx workshops and visit our booth
#1011 during AMP 2023 to learn more about our oncology and PGx testing
solutions.

Register for workshops

ONCOLOGY WORKSHOP

PGX WORKSHOP


Watch the video below to see why laboratories rely on the MassARRAY for
accurate, cost-efficient targeted results.


Video: MassARRAY® Technology Overview

Connect With Us
Pharmacogenetic testing takes a leap in California! Governor Gavin Newsom signs
AB 425, marking a historic stride by making PGx testing a covered benefit under
the Medi-Cal program, slated to commence on July 1, 2024. This revolutionary
move not only shines a beacon of hope for individualizing patient treatment
through genetic insights but also has a direct impact on tackling challenges
like the opioid crisis by curbing instances of dependency derived from genetic
variances. This new law is a significant step toward improving patient care and
standardizing PGx testing in the healthcare sector, which will reduce ER visits
and hospitalizations, advancing health equity, especially among women and people
of color.
More

We're grateful to all our team members who took time out of their workday to
join us at Fiesta Island. Your dedication to making a difference in our local
community and environment is truly inspiring. Special shoutout to our amazing
managers who supported this initiative by granting approvals for attendance!
Together, we've taken a significant step in keeping our coasts clean and
preserving the marine ecosystem.
More



ONE SYSTEM, ENDLESS TESTING POSSIBILITIES


MINIMAL BIOINFORMATICS ANALYSIS

Simplify data analysis by analyzing only specific mutations, unlike other
extensive approaches such as whole-genome sequencing. No bioinformatics team
needed!


SIMPLE WORKFLOW

Combining automation, minimal hands-on time and onboard data analysis, the
MassARRAY System utilizes a simple and fast workflow and delivers a suite of
applications.


BROAD MULTIPLEXING RANGE

Target up to 50 DNA variants in a single PCR reaction and process up to 96 or
384 reactions on a single SpectroCHIP® Array, and test hundreds of mutations in
a single workflow.


FLEXIBLE BIOMARKER DETECTION

Detect SNPs, insertions, deletions, translocations, copy number variations, and
methylation markers with one system.


MAXIMUM PRODUCTIVITY

Sample to results in a single day. Run up to eight 96-well or six 384-well
plates in a full workday with the flexibility to process two more plates
overnight.


COST-EFFECTIVE TESTING

Multiplexed analysis plus the elimination of fluorescent markers allows for the
lowest price per sample.


ABOUT AGENA BIOSCIENCE

A global company with a mission to help laboratories translate genomic
discoveries into targeted, cost-effective testing.


CONNECT






For Research Use Only. Not for use in diagnostic procedures.

© 2023 Agena Bioscience